Kenneth Pienta

Insider Reports History

Location
Lexington, MA
Signature
/s/ Kenneth Pienta by Colin Sandercock, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kenneth Pienta:

Company Role Class Num Shares Value Price $ Report Date Ownership
Cue Biopharma, Inc. Chief Medical Officer Stock Option (right to buy) 40,000 25 Mar 2022 Direct

Insider Reports Filed by Kenneth Pienta

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CUE Cue Biopharma, Inc. 25 Mar 2022 1 $0 4 Chief Medical Officer 29 Mar 2022, 16:12
CUE Cue Biopharma, Inc. 20 Dec 2021 1 $0 4 Chief Medical Officer 21 Dec 2021, 15:05